Note 8.

Debt

The components of debt for the periods indicated were as follows ($000):


	September 30,		June 30,
	2013		2013
Line of credit, interest at LIBOR, as defined, plus 1.50% and 1.25%, respectively	$	108,000	$	111,000
Term loan, interest at LIBOR, as defined, plus 1.25%		100,000		—
Yen denominated line of credit, interest at LIBOR, as defined, plus 1.50% and 1.25%, respectively		3,072		3,036

Total debt		211,072		114,036
Current portion of long-term debt		20,000		—

Long-term debt, less current portion	$	191,072	$	114,036

On September 10, 2013, the Company amended and restated its existing credit agreement. The Second Amended and Restated Credit Agreement (the “Amended Credit Facility”) provides for a revolving credit facility of $225 million (increased from $140 million), as well as a $100 million Term Loan. The Term Loan shall be re-paid in consecutive quarterly principal payments on the first business day of each January, April, July and October, with the first payment commencing on October 1, 2013, as follows: (i) twenty consecutive quarterly installments of $5 million and (ii) a final installment of all remaining principal due and payable on the maturity date. The Amended Credit Facility is unsecured, but is guaranteed by each existing and subsequently acquired or organized wholly-owned domestic subsidiary of the Company. The Company has the option to request an increase to the size of the Amended Credit Facility in an aggregate additional amount not to exceed $100 million. The Amended Credit Facility has a five-year term through September 2018 and has an interest rate of LIBOR, as defined in the agreement, plus 0.75% to 1.75% based on the Company’s ratio of consolidated indebtedness to consolidated EBITDA. Additionally, the facility is subject to certain covenants, including those relating to minimum interest coverage and maximum leverage ratios. As of September 30, 2013, the Company was in compliance with all financial covenants.

In conjunction with entering into the Amended Credit Facility, the Company incurred approximately $1.0 million of deferred financing costs which are being amortized over the term of the agreement. As a result of the overall increase in borrowing capacity, existing deferred financing costs of $0.5 million are also being amortized over the term of the Amended Credit Facility.

The Company’s Yen denominated line of credit is a 500 million Yen facility that has a five-year term through June 2016 and has an interest rate equal to LIBOR, as defined in the loan agreement, plus 0.625% to 1.50%. At September 30, 2013 and June 30, 2013, the Company had 300 million Yen borrowed. Additionally, the facility is subject to certain covenants, including those relating to minimum interest coverage and maximum leverage ratios. As of September 30, 2013, the Company was in compliance with all financial covenants.

The Company had aggregate availability of $117.8 million and $29.8 million under its lines of credit as of September 30, 2013 and June 30, 2013, respectively. The amounts available under the Company’s lines of credit are reduced by outstanding letters of credit. As of September 30, 2013 and June 30, 2013, total outstanding letters of credit supported by the credit facilities were $1.3 million.

The weighted average interest rate of total borrowings was 1.49% and 0.89% for the three months ended September 30, 2013 and 2012, respectively.

Remaining annual principal payments under the Company’s credit facility as of September 30, 2013 were as follows:


Period	Term Loan		Yen Line of Credit		U.S. Dollar Line of Credit		Total
Year 1	$	20,000	$	—	$	—	$	20,000
Year 2		20,000		—		—		20,000
Year 3		20,000		3,072		—		23,072
Year 4		20,000		—		—		20,000
Year 5		20,000		—		108,000		128,000

Total	$	100,000	$	3,072	$	108,000	$	211,072